Acquisition accelerates expansion of cold chain capabilities throughout Europe and Latin America.
Acquisition will enhance end-to-end global healthcare logistics capabilities and expand scale and expertise in Europe and Latin America.
Acquisition will enhance Marken brand as a premier clinical trial and cell and gene logistics provider in the region.
Upgrades and global expansion provide additional control, visibility, reliability, and recovery for patient-critical, time-and temperature-sensitive products.
Quality certifications for freight forwarding stations in Japan and South Korea solidify excellence in handling pharmaceutical air cargo.
UPS Healthcare will leverage its extensive cold chain capabilities to distribute Novavax's COVID-19 vaccine.